Advertisement

Index by author

April 01, 2022; Volume 101,Issue 4

  1. Newton, Alexandra C.

    1. mTOR Regulation of AGC Kinases: New Twist to an Old Tail
      Timothy R. Baffi and Alexandra C. Newton
      Molecular Pharmacology April 2022, 101 (4) 213-218; DOI: https://doi.org/10.1124/molpharm.121.000310

  2. Park, Julia

    1. Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors
      Jon Merlin, Julia Park, Teresa H. Vandekolk, Stewart A. Fabb, Jeanne Allinne, Roger J. Summers, Christopher J. Langmead and Darren M. Riddy
      Molecular Pharmacology April 2022, 101 (4) 246-256; DOI: https://doi.org/10.1124/molpharm.121.000422

  3. Pautz, Sabine

    1. The Tails of Protein Kinase A
      Susan S. Taylor, Kristoffer Søberg, Evan Kobori, Jian Wu, Sabine Pautz, Friedrich W. Herberg and Bjørn Steen Skålhegg
      Molecular Pharmacology April 2022, 101 (4) 219-225; DOI: https://doi.org/10.1124/molpharm.121.000315

  4. Riddy, Darren M.

    1. Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors
      Jon Merlin, Julia Park, Teresa H. Vandekolk, Stewart A. Fabb, Jeanne Allinne, Roger J. Summers, Christopher J. Langmead and Darren M. Riddy
      Molecular Pharmacology April 2022, 101 (4) 246-256; DOI: https://doi.org/10.1124/molpharm.121.000422

  5. Sakuma, Rika

    1. Yeast <em>β</em>-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
      Yeast β-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
      Ferbian Milas Siswanto, Akiyoshi Tamura, Rika Sakuma and Susumu Imaoka
      Molecular Pharmacology April 2022, 101 (4) 257-273; DOI: https://doi.org/10.1124/molpharm.121.000475

  6. Schmeckpeper, Jeffrey

    1. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient KV11.1 (hERG) Variants
      Christian L. Egly, Daniel J. Blackwell, Jeffrey Schmeckpeper, Brian P. Delisle, C. David Weaver and Björn C. Knollmann
      Molecular Pharmacology April 2022, 101 (4) 236-245; DOI: https://doi.org/10.1124/molpharm.121.000421

  7. Scott, Susan R.

    1. A Recombinant Dimethylarginine Dimethylaminohydrolase-1–Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity
      Young Lee, Jaipal Singh, Susan R. Scott, Bradley Ellis, Pinar Zorlutuna and Meijing Wang
      Molecular Pharmacology April 2022, 101 (4) 226-235; DOI: https://doi.org/10.1124/molpharm.121.000394

  8. Singh, Jaipal

    1. A Recombinant Dimethylarginine Dimethylaminohydrolase-1–Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity
      Young Lee, Jaipal Singh, Susan R. Scott, Bradley Ellis, Pinar Zorlutuna and Meijing Wang
      Molecular Pharmacology April 2022, 101 (4) 226-235; DOI: https://doi.org/10.1124/molpharm.121.000394

  9. Siswanto, Ferbian Milas

    1. Yeast <em>β</em>-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
      Yeast β-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway
      Ferbian Milas Siswanto, Akiyoshi Tamura, Rika Sakuma and Susumu Imaoka
      Molecular Pharmacology April 2022, 101 (4) 257-273; DOI: https://doi.org/10.1124/molpharm.121.000475

  10. Skalhegg, Bjørn Steen

    1. The Tails of Protein Kinase A
      Susan S. Taylor, Kristoffer Søberg, Evan Kobori, Jian Wu, Sabine Pautz, Friedrich W. Herberg and Bjørn Steen Skålhegg
      Molecular Pharmacology April 2022, 101 (4) 219-225; DOI: https://doi.org/10.1124/molpharm.121.000315
« Previous (Pages : 1 2 3 4 5 ... 5) Next »
Back to top

In this issue

Advertisement